These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3011165)

  • 41. Receptor organization of opioid and adrenergic regulation of pain.
    Ignatov YuD ; Zaitsev AA
    Ann Ist Super Sanita; 1988; 24(3):405-9. PubMed ID: 2903709
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
    Shippenberg TS; Herz A
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1101-6. PubMed ID: 1848627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus.
    Pilcher CW; Browne JL
    NIDA Res Monogr; 1986; 75():469-72. PubMed ID: 2828994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Specificity of the anti-arrhythmic effect of kappa1-opioid receptor agonists].
    Ugdyzhekova DS; Maslov LN; Krylatov AV; Lishmanov IuB; Tam SV
    Eksp Klin Farmakol; 2001; 64(4):17-20. PubMed ID: 11589101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic kappa-opioid receptor antagonism delays the rise in blood pressure in spontaneously hypertensive rats.
    Kraft K; Diehl J; Egen A; Stumpe KO
    Eur J Pharmacol; 1991 Aug; 200(2-3):219-26. PubMed ID: 1664325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endorphin mechanisms are responsible for the beneficial effects of opioid antagonists on cerebral function during relative cerebral ischaemia in rats.
    Skarphedinsson JO; Thorén P
    Acta Physiol Scand; 1988 Mar; 132(3):281-8. PubMed ID: 2852436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential stereospecific effects of mu, kappa, and sigma opioid agonists on cortical EEG power spectra in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1983 Apr; 43():190-5. PubMed ID: 6308453
    [No Abstract]   [Full Text] [Related]  

  • 49. Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotide probe effects in mice and rats.
    Hadjimarkou MM; Singh A; Kandov Y; Israel Y; Pan YX; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1188-202. PubMed ID: 15333676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
    Sun W; Wainwright CL
    Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
    Summy-Long JY; Rosella-Dampman LM; McLemore GL; Koehler E
    Neuroendocrinology; 1990 Apr; 51(4):376-84. PubMed ID: 1971712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynorphin1-17 can enhance or impair retention of an inhibitory avoidance response in rats.
    del Cerro S; Borrell J
    Life Sci; 1990; 47(16):1453-62. PubMed ID: 1979136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naloxone reversal of ischemic arrhythmia is stereospecific and suggests role of endogenous opioid peptides in ischemic heart disease.
    Kan MN; Chen YT; Lee AY
    Proc Soc Exp Biol Med; 1992 Sep; 200(4):518-21. PubMed ID: 1508943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of SK&F 93479 on experimentally induced ventricular arrhythmias in dogs, rats and mice.
    Dai S
    Agents Actions; 1984 Oct; 15(3-4):131-6. PubMed ID: 6151803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmic effects of Org 6001 in rats: correlation with plasma and tissue drug concentrations.
    Kane K; McDonald F; Parratt J; Timmer C; Vink J
    Br J Pharmacol; 1982 Feb; 75(2):319-23. PubMed ID: 7186821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.
    Hashimoto Y; Hori R; Okumura K; Yasuhara M
    Br J Pharmacol; 1986 May; 88(1):71-7. PubMed ID: 3708225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.
    Curtis MJ; Walker MJ
    Cardiovasc Res; 1988 Sep; 22(9):656-65. PubMed ID: 3242835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereospecific reduction by narcotic antagonists of clonidine-induced food intake.
    Katz NL; Schlemmer RF; Waller DP
    Pharmacol Biochem Behav; 1985 Apr; 22(4):649-51. PubMed ID: 3991774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.
    Wentland MP; Sun X; Cohen DJ; Bidlack JM
    Bioorg Med Chem; 2008 May; 16(10):5653-64. PubMed ID: 18417347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiarrhythmic effect of antibodies to digoxin in acute myocardial ischemia in rats.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukayatkina NI; Stolba P; Zhabko EP
    Eur J Pharmacol; 1989 Mar; 162(1):195-6. PubMed ID: 2542054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.